Introduction
Methods
Compliance with Ethics Guidelines
Study Population and Measurements
Genetic Analysis
SNP ID | Context sequence [VIC/FAM] | Position |
---|---|---|
rs2069952 | GCACCCTCTCTGCACAGTCCCCTGA[C/T]CCTGACTGTCTATCCACAGTTCCTC | Intron 2 |
rs2069940 | GTTTCAAAAAGATTGCTTTAGGTAA[C/G]CAATCATCTTCTGAGATTTATACAG | 5′ UTR |
rs867186 | GCTGGTCCTGGGCGTCCTGGTGGGC[A/G]GTTTCATCATTGCTGGTGTGGCTGT | Exon 4 |
sEPCR Antigen Measurement
Statistical Analysis
Results
Characteristics of the Study Population
Parameters | All patients |
---|---|
Number of patients (N) | 239 |
sEPCR (ng/ml) | 192 (136–245) |
Diagnosis | |
Medical | 88 (36.8%) |
Surgical | 98 (41.0%) |
Trauma | 53 (22.2%) |
APACHE II score | 22 (16–27) |
SOFA score | 8 (6–11) |
Age (years) | 60 ± 18 |
Sex | |
Male | 166 (69.5%) |
Female | 73 (30.5%) |
ARDS | 46 (19.3%) |
Mortality | 98 (41.0%) |
Length of stay (days) | 10 (3–25) |
EPCR Polymorphisms and sEPCR Levels
Classification | SS/SS-positive (N = 139) [%] | SS/SS-negative (N = 100) [%] | qSOFA 1 (N = 7) [%] | qSOFA 2 (N = 197) [%] | qSOFA 3 (N = 35) [%] | All patients (N = 239) [%] | p value |
---|---|---|---|---|---|---|---|
Allele | |||||||
H3 | 10.4 | 15.5 | 7.0 | 13.2 | 10.0 | 12.6 | ns |
H1 | 34.2 | 34.5 | 50.0 | 32.5 | 34.3 | 33.3 | ns |
H2 | 55.4 | 50.0 | 43.0 | 54.3 | 55.7 | 54.1 | ns |
Variable | OR | 95% CI |
p
|
---|---|---|---|
Genotype combination | |||
Only H3 | Reference | ||
H2 | 0.266 | 0.094–0.754 | 0.013* |
Only H1 | 0.222 | 0.082–0.600 | 0.003* |
H1 and H3 | 0.717 | 0.177–2.912 | 0.642 |
Alleles | |||
H3 | Reference | ||
H1 | 0.272 | 0.126–0.587 | 0.001* |
Diagnosis | |||
Trauma | Reference | ||
Medical | 0.366 | 0.149–0.899 | 0.028* |
Surgical | 0.276 | 0.115–0.665 | 0.004* |
APACHE II score | 0.865 | 0.825–0.908 | < 0.0001* |